Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Confirma and Guardian link up in radiology strategic alliance:

This article was originally published in Clinica

Executive Summary

CAD firm Confirma has signed a strategic alliance agreement with Guardian Technologies, to collaborate on the design, development and commercialisation of radiology imaging solutions for new clinical applications. Guardian Technologies will bring to the alliance its patent-pending CAD technology based on a mathematical algorithm - called intelligent imaging informatics (3i) - that can be trained to recognise patterns in organic material, or generate "Signature Maps" relating to individual disease states. The technology has shown promise in imaging breast lesions in mammography said the Herndon, Virginia firm. It has also yielded encouraging results for MR imaging of multiple sclerosis lesions. Early studies have shown possible uses for the technology in prostate MRI and CT brain scans. Bellevue, Washington-based Confirma already has over 700 CAD systems for breast MRI installed worldwide.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048277

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel